Literature DB >> 12931214

Comprehensive analysis of gene alterations in acute megakaryoblastic leukemia of Down's syndrome.

Y Hirose, K Kudo, H Kiyoi, Y Hayashi, T Naoe, S Kojima.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12931214     DOI: 10.1038/sj.leu.2403121

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  A mutation in the translation initiation codon of Gata-1 disrupts megakaryocyte maturation and causes thrombocytopenia.

Authors:  Ian J Majewski; Donald Metcalf; Lisa A Mielke; Danielle L Krebs; Sarah Ellis; Marina R Carpinelli; Sandra Mifsud; Ladina Di Rago; Jason Corbin; Nicos A Nicola; Douglas J Hilton; Warren S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

Review 2.  Myeloid leukemia in Down syndrome.

Authors:  Irum Khan; Sébastien Malinge; John Crispino
Journal:  Crit Rev Oncog       Date:  2011

Review 3.  The biology of pediatric acute megakaryoblastic leukemia.

Authors:  Tanja A Gruber; James R Downing
Journal:  Blood       Date:  2015-07-17       Impact factor: 22.113

Review 4.  Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.

Authors:  Sébastien Malinge; Shai Izraeli; John D Crispino
Journal:  Blood       Date:  2009-01-12       Impact factor: 22.113

5.  Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes.

Authors:  Sébastien Malinge; Tim Chlon; Louis C Doré; Rhett P Ketterling; Martin S Tallman; Elisabeth Paietta; Alan S Gamis; Jeffrey W Taub; Stella T Chou; Mitchell J Weiss; John D Crispino; Maria E Figueroa
Journal:  Blood       Date:  2013-08-26       Impact factor: 22.113

6.  Mosaic Trisomy 21 and Trisomy 14 as Acquired Cytogenetic Abnormalities without GATA1 Mutation in A Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia.

Authors:  Yi Xiao; Jia Wei; Jin-Huan Xu; Jian-Feng Zhou; Yi-Cheng Zhang
Journal:  Chin J Cancer Res       Date:  2011-09       Impact factor: 5.087

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.